Administration of GLP-1 or GLP-1RAs (including exenatide, geniposide, liraglutide, lixisenatide, and semaglutide) enhances neurogenesis in the dentate gyrus, hippocampus, olfactory bulb, and medial striatum in animal models, while modulating apoptotic pathways and increasing animal survival under extreme factors [24]
References: Patients who lose less than 20 pounds on GLP-1 treatment lose more weight after switching to phentermine
Your reasoning for seeking medical support is valid
The diet plan principles for GLP-1 agonists should be implemented from day one, not after problems arise
Reduced Inflammation : Chronic inflammation is a common factor in many diseases, including autoimmune disorders and chronic infections
The presentation was related to visfatin in cancers